SCHEMBL23009

SCHEMBL23009

O=C(O)CC(C(=O)O)C(CC(=O)O)P(=O)(O)O

nearest known ligand 0.56

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.56
FOLH1 Q04609 7/20 0.48
CA2 P00918 1/20 0.41
CA4 P22748 1/20 0.41
MEN1 O00255 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
TSHR P16473 1/20 0.39
BLM P54132 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.37
NAALAD2 Q9Y3Q0 1/20 0.36
SLC22A6 Q4U2R8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28035961 0.87 FOLH1 (0.55) TDP1FOLH1CA2CA4MEN1
SCHEMBL8634272 0.85 TDP1 (0.50) TDP1FOLH1CA2CA4MEN1
SCHEMBL11406345 0.84 FOLH1 (0.52) TDP1FOLH1NAALAD2
SCHEMBL28800516 0.83 FOLH1 (0.52) TDP1FOLH1CA2CA4MEN1
Butedronic Acid SCHEMBL645294 0.79 TDP1 (0.59) TDP1FOLH1CA2CA4MEN1
Phosphoric Acid SCHEMBL9456210 0.78 TDP1 (0.74) TDP1FOLH1CA2CA4MEN1
Butedronic Acid SCHEMBL11226134 0.77 TDP1 (0.56) TDP1FOLH1CA2CA4MEN1
SCHEMBL2764210 0.77 TDP1 (0.56) TDP1FOLH1CA2CA4MEN1
SCHEMBL490757 0.77 TDP1 (0.64) TDP1FOLH1CA2CA4MEN1
SCHEMBL8709925 0.77 FOLH1 (0.48) TDP1FOLH1CA2CA4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4204381-B1 SET CONTROL COMPOSITION FOR CEMENTITIOUS SYSTEMS CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2026-05-06 EP disclosed
US-12595209-B2 Mixture comprising glyoxylic acid or condensation or addition products thereof BASF SE (DE) 2026-04-07 US disclosed
US-12534405-B2 Shotcrete composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2026-01-27 US disclosed
US-12415752-B2 Construction composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2025-09-16 US disclosed
US-20250276938-A1 DRY MORTAR COMPOSITION CONTAINING METAL SALT OF A POLYOL BASF SE (DE) 2025-09-04 US disclosed
EP-4522577-A1 DRY MORTAR COMPOSITION CONTAINING METAL SALT OF A POLYOL BASF SE (DE) 2025-03-19 EP disclosed
CN-119173489-A Dry mortar composition containing metal salts of polyols 巴斯夫欧洲公司 2024-12-20 CN disclosed
US-20240174568-A1 CEMENTITIOUS COMPOSITION BASF SE (DE) 2024-05-30 US disclosed
US-11981606-B2 Cement-reduced construction composition CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2024-05-14 US disclosed
EP-4204382-B1 LIMESTONE CALCINED CLAY CEMENT (LC3) CONSTRUCTION COMPOSITION CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) 2024-03-27 EP disclosed
US-8608847-B2 Accelerator for hydraulic binders SIKA TECHNOLOGY AG (CH) 2013-12-17 US disclosed
EP-2609055-A1 ACCELERATOR Sika Technology AG (CH) 2013-07-03 EP disclosed
US-20130112116-A1 ACCELERATOR FOR HYDRAULIC BINDERS SIKA TECHNOLOGY AG (CH) 2013-05-09 US disclosed
WO-2012025567-A1 ACCELERATOR SIKA TECHNOLOGY AG (CH) 2012-03-01 WO disclosed
EP-2423175-A1 Accelerator for hydraulic binders Sika Technology AG (CH) 2012-02-29 EP disclosed
US-5273549-A Crosslinking agent containing at least two carboxyl groups and a phosphate group SOCIETE FRANCAISE HOECHST (FR) 1993-12-28 US disclosed
EP-0516305-A1 Simultaneous use of water soluble polymers with ozone in cooling water systems NALCO CHEMICAL COMPANY (US) 1992-12-02 EP disclosed
EP-0508158-A2 Set retarder for wet spraying Sika AG, vorm. Kaspar Winkler & Co. (CH) 1992-10-14 EP disclosed
US-4265769-A CORROSION RESISTANCE, ANTISCALING AGENTS CIBA-GEIGY CORPORATION (US) 1981-05-05 US disclosed
US-4208344-A CORROSION RESISTANCE, ANTISCALING AGENTS CIBA-GEIGY CORPORATION (US) 1980-06-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12595209-B2 Mixture comprising glyoxylic acid or condensation or addition products thereof PLOD1, AGXT, ME1 TDP1 4057/4885FOLH1 2482/4885CA2 36/4885
US-12534405-B2 Shotcrete composition EXOSC10, S100A10, ATXN10 TDP1 2438/4885FOLH1 1471/4885CA2 373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.